nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—Mepyramine—Rosiglitazone—type 2 diabetes mellitus	0.144	0.418	CrCrCtD
Brompheniramine—CYP2E1—type 2 diabetes mellitus	0.132	0.614	CbGaD
Brompheniramine—Chloropyramine—Rosiglitazone—type 2 diabetes mellitus	0.13	0.376	CrCrCtD
Brompheniramine—CYP3A4—type 2 diabetes mellitus	0.0833	0.386	CbGaD
Brompheniramine—Tripelennamine—Rosiglitazone—type 2 diabetes mellitus	0.071	0.206	CrCrCtD
Brompheniramine—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0204	0.0544	CbGbCtD
Brompheniramine—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0163	0.0435	CbGbCtD
Brompheniramine—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0148	0.0393	CbGbCtD
Brompheniramine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0146	0.0388	CbGbCtD
Brompheniramine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0142	0.0379	CbGbCtD
Brompheniramine—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0136	0.0363	CbGbCtD
Brompheniramine—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0132	0.0351	CbGbCtD
Brompheniramine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.013	0.0347	CbGbCtD
Brompheniramine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0124	0.033	CbGbCtD
Brompheniramine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0124	0.033	CbGbCtD
Brompheniramine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0121	0.0323	CbGbCtD
Brompheniramine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0114	0.0305	CbGbCtD
Brompheniramine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.011	0.0294	CbGbCtD
Brompheniramine—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0107	0.0286	CbGbCtD
Brompheniramine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0103	0.0274	CbGbCtD
Brompheniramine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0103	0.0274	CbGbCtD
Brompheniramine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0095	0.0253	CbGbCtD
Brompheniramine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00941	0.0251	CbGbCtD
Brompheniramine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00929	0.0248	CbGbCtD
Brompheniramine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00917	0.0245	CbGbCtD
Brompheniramine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00868	0.0232	CbGbCtD
Brompheniramine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00839	0.0224	CbGbCtD
Brompheniramine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00828	0.0221	CbGbCtD
Brompheniramine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0078	0.0208	CbGbCtD
Brompheniramine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00757	0.0202	CbGbCtD
Brompheniramine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00748	0.0199	CbGbCtD
Brompheniramine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00713	0.019	CbGbCtD
Brompheniramine—CYP2C8—Losartan—type 2 diabetes mellitus	0.00691	0.0184	CbGbCtD
Brompheniramine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00684	0.0182	CbGbCtD
Brompheniramine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00662	0.0176	CbGbCtD
Brompheniramine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00634	0.0169	CbGbCtD
Brompheniramine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00598	0.016	CbGbCtD
Brompheniramine—CYP2C19—Losartan—type 2 diabetes mellitus	0.0058	0.0155	CbGbCtD
Brompheniramine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00527	0.014	CbGbCtD
Brompheniramine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00482	0.0128	CbGbCtD
Brompheniramine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00454	0.0121	CbGbCtD
Brompheniramine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00435	0.0116	CbGbCtD
Brompheniramine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00435	0.0116	CbGbCtD
Brompheniramine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00411	0.011	CbGbCtD
Brompheniramine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00306	0.00817	CbGbCtD
Brompheniramine—CYP3A4—Losartan—type 2 diabetes mellitus	0.0028	0.00747	CbGbCtD
Brompheniramine—Captodiame—HTR2C—type 2 diabetes mellitus	0.000303	0.27	CrCbGaD
Brompheniramine—Carbinoxamine—CYP2E1—type 2 diabetes mellitus	0.000127	0.113	CrCbGaD
Brompheniramine—Tolterodine—CYP3A4—type 2 diabetes mellitus	9.35e-05	0.0833	CrCbGaD
Brompheniramine—Promazine—ADRA2A—type 2 diabetes mellitus	8.69e-05	0.0774	CrCbGaD
Brompheniramine—Carbinoxamine—CYP3A4—type 2 diabetes mellitus	8.03e-05	0.0715	CrCbGaD
Brompheniramine—Promazine—HTR2C—type 2 diabetes mellitus	8e-05	0.0712	CrCbGaD
Brompheniramine—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	7e-05	0.0623	CrCbGaD
Brompheniramine—Orphenadrine—CYP2E1—type 2 diabetes mellitus	6.95e-05	0.0619	CrCbGaD
Brompheniramine—Chlorphenamine—CYP3A4—type 2 diabetes mellitus	6.82e-05	0.0608	CrCbGaD
Brompheniramine—Promazine—CYP1A2—type 2 diabetes mellitus	6.03e-05	0.0537	CrCbGaD
Brompheniramine—Orphenadrine—CYP3A4—type 2 diabetes mellitus	4.38e-05	0.039	CrCbGaD
Brompheniramine—Promazine—CYP3A4—type 2 diabetes mellitus	3.99e-05	0.0356	CrCbGaD
Brompheniramine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.52e-06	4.01e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.52e-06	4.01e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	2.52e-06	4e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	2.51e-06	4e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.51e-06	3.99e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.51e-06	3.99e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.5e-06	3.97e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.5e-06	3.97e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.49e-06	3.97e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.49e-06	3.95e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.47e-06	3.93e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.47e-06	3.93e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	2.47e-06	3.92e-05	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.46e-06	3.91e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.46e-06	3.91e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.46e-06	3.91e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.46e-06	3.91e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.45e-06	3.9e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.44e-06	3.88e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.44e-06	3.88e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.44e-06	3.87e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.43e-06	3.87e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.42e-06	3.85e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.41e-06	3.84e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	2.41e-06	3.83e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	2.41e-06	3.83e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	2.41e-06	3.83e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.41e-06	3.83e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.4e-06	3.82e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.4e-06	3.82e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.4e-06	3.81e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.4e-06	3.81e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	2.39e-06	3.8e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.38e-06	3.79e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.38e-06	3.78e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.37e-06	3.78e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.37e-06	3.77e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.37e-06	3.77e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	2.36e-06	3.76e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	2.36e-06	3.75e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	2.35e-06	3.74e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	2.34e-06	3.72e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.34e-06	3.72e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.34e-06	3.72e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.33e-06	3.71e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.32e-06	3.68e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	2.31e-06	3.68e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	2.31e-06	3.68e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	2.31e-06	3.68e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	2.3e-06	3.66e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.3e-06	3.66e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	2.3e-06	3.65e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.29e-06	3.65e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.28e-06	3.62e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	2.27e-06	3.62e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.27e-06	3.62e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.27e-06	3.62e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.27e-06	3.6e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.26e-06	3.59e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.24e-06	3.57e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.24e-06	3.57e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.24e-06	3.56e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.24e-06	3.56e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.24e-06	3.56e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.23e-06	3.55e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.23e-06	3.55e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.23e-06	3.54e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.23e-06	3.54e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.23e-06	3.54e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.22e-06	3.54e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.22e-06	3.53e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.22e-06	3.53e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.22e-06	3.53e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.22e-06	3.53e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—SRC—type 2 diabetes mellitus	2.22e-06	3.52e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.21e-06	3.52e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.2e-06	3.5e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.2e-06	3.5e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.2e-06	3.5e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	2.2e-06	3.5e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.2e-06	3.5e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.2e-06	3.5e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.2e-06	3.5e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.19e-06	3.48e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.18e-06	3.47e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	2.17e-06	3.44e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.16e-06	3.44e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.16e-06	3.44e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.16e-06	3.43e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.15e-06	3.42e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.14e-06	3.41e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.13e-06	3.39e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.13e-06	3.39e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.12e-06	3.38e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—SRC—type 2 diabetes mellitus	2.12e-06	3.38e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	2.12e-06	3.37e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.12e-06	3.37e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.11e-06	3.35e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.1e-06	3.34e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.1e-06	3.34e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.09e-06	3.32e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.09e-06	3.32e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.07e-06	3.3e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	2.07e-06	3.3e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.07e-06	3.29e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.07e-06	3.29e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.06e-06	3.28e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.05e-06	3.26e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	2.04e-06	3.24e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.03e-06	3.23e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	2.03e-06	3.23e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.03e-06	3.22e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.03e-06	3.22e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.03e-06	3.22e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.02e-06	3.21e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.02e-06	3.21e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.02e-06	3.21e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.01e-06	3.2e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.01e-06	3.2e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.01e-06	3.19e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	2e-06	3.18e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.99e-06	3.17e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.99e-06	3.17e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.99e-06	3.17e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.99e-06	3.17e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.98e-06	3.15e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.96e-06	3.12e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.94e-06	3.09e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.94e-06	3.09e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.93e-06	3.07e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.92e-06	3.06e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.91e-06	3.04e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.91e-06	3.04e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.91e-06	3.04e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.91e-06	3.03e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.91e-06	3.03e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.9e-06	3.02e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.9e-06	3.02e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.9e-06	3.02e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	1.9e-06	3.01e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	1.89e-06	3.01e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.88e-06	3e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.88e-06	2.99e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.86e-06	2.96e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	1.86e-06	2.95e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	1.83e-06	2.92e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.82e-06	2.89e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.78e-06	2.84e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	1.75e-06	2.79e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	1.75e-06	2.79e-05	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.74e-06	2.76e-05	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.73e-06	2.75e-05	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.73e-06	2.74e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.72e-06	2.74e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.71e-06	2.73e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.71e-06	2.72e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.71e-06	2.72e-05	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.71e-06	2.72e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.7e-06	2.71e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.7e-06	2.7e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.69e-06	2.69e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.68e-06	2.68e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.67e-06	2.66e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.66e-06	2.64e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.65e-06	2.62e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.65e-06	2.62e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.64e-06	2.61e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.64e-06	2.61e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.64e-06	2.6e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.63e-06	2.59e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.63e-06	2.59e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.62e-06	2.58e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.62e-06	2.57e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.62e-06	2.57e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.61e-06	2.56e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	1.6e-06	2.55e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.6e-06	2.55e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.6e-06	2.54e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.6e-06	2.54e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.58e-06	2.52e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.58e-06	2.51e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.57e-06	2.5e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.57e-06	2.5e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.57e-06	2.49e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.57e-06	2.49e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.57e-06	2.49e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.55e-06	2.47e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.53e-06	2.43e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.51e-06	2.39e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.5e-06	2.38e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.5e-06	2.38e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.49e-06	2.38e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL6—type 2 diabetes mellitus	1.49e-06	2.37e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.49e-06	2.37e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.49e-06	2.37e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.47e-06	2.35e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.47e-06	2.33e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.46e-06	2.33e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.46e-06	2.32e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.46e-06	2.31e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.45e-06	2.31e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.44e-06	2.29e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.44e-06	2.29e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.44e-06	2.28e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.43e-06	2.28e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	1.43e-06	2.27e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.43e-06	2.27e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.43e-06	2.27e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.42e-06	2.27e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.41e-06	2.24e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.38e-06	2.19e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.35e-06	2.15e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.34e-06	2.13e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.34e-06	2.12e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.33e-06	2.12e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.32e-06	2.11e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.32e-06	2.1e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.32e-06	2.1e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.32e-06	2.09e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.31e-06	2.09e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.31e-06	2.08e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.31e-06	2.08e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.31e-06	2.08e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.29e-06	2.06e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.28e-06	2.04e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.26e-06	2.01e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.26e-06	2e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.24e-06	1.98e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	1.11e-06	1.76e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.09e-06	1.74e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.07e-06	1.71e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.01e-06	1.61e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.01e-06	1.6e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	1e-06	1.6e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	9.93e-07	1.58e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	9.84e-07	1.57e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	9.52e-07	1.51e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	9.41e-07	1.5e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	9.41e-07	1.5e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	9.33e-07	1.48e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.31e-07	1.48e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.28e-07	1.48e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.26e-07	1.47e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.17e-07	1.46e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	8.61e-07	1.37e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	8.06e-07	1.28e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	7.2e-07	1.14e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	6.62e-07	1.05e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	6.56e-07	1.04e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	4.33e-07	6.88e-06	CbGpPWpGaD
